Climb Bio Inc., a clinical-stage biotechnology company focused on developing therapeutics for immune-mediated diseases, is set to participate in the Cantor Global Healthcare Conference on September 5, 2025, in New York, NY. The company will engage in a fireside chat and hold one-on-one investor meetings during the event.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Climb Bio Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9516327-en) on August 25, 2025, and is solely responsible for the information contained therein.